CSIO transfers technology to industry
Tribune News Service
Chandigarh, January 17
The Central Scientific Instruments Organisation (CSIO) here today transferred the knowhow for manufacturing “3D Printed Patient Specific Medical Implants” to a private industry for commercial production and marketing.
Patient Specific Implant (PSI) is required when current commercially available implants for the site are either not available or do not fulfil the anatomical requirement. In those cases, PSI is designed for one particular patient from the CT scan data and then manufactured using 3D printing technology using titanium or other biocompatible materials.
The requirement may arise due to trauma, diseases such as cancer or fungal infection or revision surgeries. The PSI is also beneficial for joint salvaging surgeries where human joints are good but the bone near joints is infected or traumatised. The CSIO has developed the technology and expertise of PSI development for load bearing and non-load bearing anatomical sites.
Prof RK Sinha, Director, CSIO, said the PSI was developed at the CSIO’s Innovative Additive Research and Manufacturing Laboratory (iARM ), which is having all facilities related to design, manufacturing and testing of standards as well as patient-specific orthopaedic and maxillofacial implants, surgical models, surgical tools, custom-made prosthetics, tissues engineering and organ printing.
Vijay Kumar Meena, Principal Scientist, CSIO, who has developed the knowhow of the PSI, said he and his team were working on development of technologically advanced 3D printed implants in India. The patient specific implants developed in iARM Lab were successfully implanted in patients at prestigious government and private medical institutes. The medical applications of 3D printing are continuously increasing day by day. Digital healthcare, including imaging-based technologies such as CT scan, MRI and ultrasound and medical implants, will sooner or later become routine.
